Press Release is enclosed.
IKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Inventurus Knowledge Solutions (IKS Health) reported strong FY26 results with revenue of ₹31,938 million, marking 20% year-over-year growth. Profit After Tax surged 48% to ₹7,216 million, while EBITDA jumped 38% to ₹10,913 million. The company, which provides AI-enabled healthcare solutions for US health systems, saw margin expansion with EBITDA margin improving from ~30% to ~34%. Q4 FY26 also showed solid growth with 18.5% YoY revenue increase and 39.4% PAT growth. Key highlights include new AI product launches like MyCareHub and an autonomous RCM coding engine achieving 95% accuracy, plus expansion of partnerships with major US health systems.
The results indicate strong operational execution and margin expansion, positioning the company well for continued growth. The 20% revenue growth and 48% PAT surge are positive signals for shareholders, though the stock may already reflect recent listing gains.